Progenics Pharmaceuticals, Inc. News
Lantheus Acquires Progenics in All-Stock Deal, Both Companies Drop in Trading
Lantheus will acquire oncology medicine developer Progenics Pharmaceuticals in an all-stock deal.
Biotech premarket movers: Progenics, Alexion, BioCryst
Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.
Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock
Trade-Ideas LLC identified Progenics Pharmaceuticals (PGNX) as a "perilous reversal" (up big yesterday but down big today) candidate
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.